Normal function · from ai-gene-review (Q13562, commit e7236877cf14) · AI-generated, not KB evidence

NEUROD1 (Neurogenic differentiation factor 1, also known as NeuroD, NeuroD1, BETA2, or BHLHA3) is a Group A basic helix-loop-helix (bHLH) transcription factor with dual essential roles in neuronal and pancreatic endocrine development. The protein functions in the nucleus where it binds E-box motifs (CANNTG) to activate lineage-specific transcriptional programs. NEUROD1 heterodimerizes with class I bHLH E proteins (e.g., TCF12/E2-2, E47) and cooperates with lineage-specific transcription factors to regulate chromatin accessibility and gene expression. In the nervous system, NEUROD1 is essential for neuronal survival, differentiation, and maturation in multiple regions including hippocampus and inner ear, directly activating neural genes such as Pou3f2, Insm1, Nhlh1, Atoh1, Neurod4, and Nhlh2. In the pancreas, NEUROD1 is critical for endocrine differentiation and β-cell development, supporting expression of key β-cell transcription factors (MAFA, NKX6-1, PDX1, INSM1, NKX2-2, ISL1, PAX6, RFX6) and insulin gene transcription. Human NEUROD1 mutations cause MODY6 diabetes. NEUROD1 can act as a pioneer-like factor in context-dependent manner and is widely used in cellular reprogramming protocols. NEUROD1-high expression defines a molecular subtype of small cell lung cancer.

NEUROD1's core function is as a sequence-specific DNA-binding transcriptional activator that binds E-box motifs (CANNTG) in the nucleus to activate lineage-specific transcriptional programs. It has dual essential roles: (1) in the nervous system, activating programs for neuronal differentiation, survival, and maturation, directly regulating genes like Pou3f2, Insm1, Nhlh1, Atoh1, Neurod4, and Nhlh2; and (2) in the pancreas, driving endocrine differentiation and β-cell development/maturation, supporting expression of critical β-cell transcription factors (MAFA, NKX6-1, PDX1, INSM1, NKX2-2, ISL1, PAX6, RFX6) and insulin gene transcription. NEUROD1 functions through heterodimerization with E-proteins (E47/TCF12) and cooperation with other lineage-specific transcription factors. It engages chromatin and can act as a pioneer-like factor in context-dependent manner. This is a genuinely pleiotropic gene with two core functional domains (neural and endocrine) rather than one core function with peripheral roles.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Diabetes mellitus causative
mechanism: Monogenic Beta-Cell Dysfunction
subtype: maturity-onset diabetes of the young type 6
scoped to subtype: maturity-onset diabetes of the young type 6
Olfactory Neuroblastoma no genetic record
mechanism: Retained Globose Basal Cell Transcriptional Programme
ClinGen gene–disease validity · snapshot 2026-10-24 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
monogenic diabetes MONDO:0015967 AD Moderate
2026-02-23
monogenic diabetes MONDO:0015967 AR Moderate
2021-03-10

Identity from HGNC (snapshot 2026-10-24). Page layers are described in the gene pages documentation.